Absci Corp

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$5.76

+0.01 (+0.17%)

As of May 9, 1:51 AM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 13 87%

Hold 2 13%

Sell 0 0%

Price Target

Analyst Price Target +308.9% upside

Low Target $16.79

Average Target $23.55

High Target $35.63

Current Price $5.76

Current
$5.76

Target
$23.55

$16.79 $23.55 avg $35.63

Scenario Analysis

Bear Case

$16.79

191.5%

Low target

Base Case

$23.55

+308.9%

Avg target

Bull Case

$35.63

+518.6%

High target

Risk/Reward

2.7x

Favorable

Price in Context

52-Week High

$6.24

-7.6% from high

52-Week Low

$2.24

+157.1% from low

Target vs 52W High

$23.55

+277.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+27.8%
AMGN Amgen Inc	Hold	44	48%	$190.87	-42.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+176.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.3%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-19.5%
INSM Insmed Inc	Strong Buy	28	96%	$143.40	+41.5%